Accelerating Drug Development through RWE in China

2 blank lines

<div id="cincopa_1b3839" style="border:solid;border-width:1px"></div><script type="text/javascript">
var cpo = []; cpo["_object"] ="cincopa_1b3839"; cpo["_fid"] = "AICA2-uFRBcT";
var _cpmp = _cpmp || []; _cpmp.push(cpo);
(function() { var cp = document.createElement("script"); cp.type = "text/javascript";
cp.async = true; cp.src = "https://rtcdn.cincopa.com/libasync.js";
var c = document.getElementsByTagName("script")[0];
c.parentNode.insertBefore(cp, c); })(); </script>

On-Demand Webinar - HLT - Video

<br><div style="padding-right:60px;">
### ON-DEMAND RECORDING
**RECORDED: November 3, 2021** <br><br>

Industry KOLs discussed findings from a recent survey from BioCentury and Happy Life Tech on Real World Evidence (RWE) and opportunities for Western biopharmas to accelerate drug development via RWE studies in China.<br><br>

Plus, GU Gang, senior official from China's Hainan Medical Tourism Pilot Zone, discusses the special Bo'ao RWE approval pathway for Western and China biopharma and medtech innovators.<br><br>

</div>
<br><br>

On-Demand Webinar - HLT - Description

<br>
### HOSTED BY
<br><br>
<p>
<img src="https://media.graphassets.com/Uw0f60cZQvuhNRZYAhzJ" alt="BioCentury Logo" width="250" style="horizontal-align:center"><br><br><br>
<img src="https://media.graphassets.com/p97r7kHdRGyEx68daYfb" alt="HLT Logo" width="250" style="horizontal-align:center"></p>


On-Demand Webinar - HLT - Hosted by BC & HLT

1 blank line

Executive Director of Biopharma Intelligence

Lauren Martz

Executive Director

Boxiong Tang, Ph.D.

VP of iHS Global

Mei Yang, Ph.D.

Executive Director, China RWE

Haijun Tian, Ph.D.

FDA Liaison & Head of U.S. Regulatory Policy

Andrew Emmett

3 blank lines

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

BioCentury-BIA Jefferies 2024

East-West Healthcare Reception

The BioCentury-BayHelix East-West BioPharma Summit

BioCentury-BayHelix East-West Summit

Bio€quity Europe

BioCentury Grand Rounds Inquiry

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Sponsorship & Branding Inquiry 

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Industry KOLs discussed findings from a recent survey from BioCentury and Happy Life Tech on Real World Evidence (RWE) and opportunities for Western biopharmas to accelerate drug development via RWE studies in China.